Compare $ATNM vs $GRDX | Chartloom

Compare

$ATNM vs $GRDX

Actinium Pharmaceuticals Inc · GridAI Technologies Corp

ATNM

Actinium Pharmaceuticals Inc

GRDX

GridAI Technologies Corp

Compare $ATNM vs $GRDX

Comparing Actinium Pharmaceuticals Inc and GridAI Technologies Corp

ATNMActinium Pharmaceuticals Inc

GRDXGridAI Technologies Corp

ATNMActinium Pharmaceuticals Inc

Market cap

$35M

P/E (TTM)

3.06x

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-19.7%

52W performance

-28.6%

FCF yield

-67.4%

GRDXGridAI Technologies Corp

Market cap

$34M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-3.3%

52W performance

24.2%

FCF yield

-24.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ATNM

GRDX

Detailed metrics comparison

ATNM

Actinium Pharmaceuticals Inc

GRDX

GridAI Technologies Corp

Market Cap

ATNM$35M

GRDX$34M

Enterprise Value

ATNM$-2M

GRDX$34M

Price

ATNM$1.10

GRDX$4.97

P/E Ratio

ATNM3.06x

GRDXN/A

P/S Ratio

ATNM0.98x

GRDX209.46x

EV/Sales

ATNM-0.06x

GRDX211.31x

EV/EBITDA

ATNM-0.20x

GRDX0.00x

P/B Ratio

ATNM1.21x

GRDX1.94x

P/FCF Ratio

ATNMN/A

GRDXN/A

EV/FCF

ATNM0.08x

GRDX-4.17x

PEG Ratio

ATNMN/A

GRDXN/A

Forward P/E (NTM)

ATNMN/A

GRDXN/A

Forward P/S (NTM)

ATNMN/A

GRDXN/A

Revenue (TTM)

ATNM$35M

GRDX$160K

Revenue Growth (YoY)

ATNMN/A

GRDXN/A

Forward Rev Growth

ATNM-0.2%

GRDX0.0%

Gross Margin (TTM)

ATNM0.0%

GRDX-815.2%

Operating Margin (TTM)

ATNM62.3%

GRDX0.0%

EBITDA Margin (TTM)

ATNM27.9%

GRDX-6577.4%

Net Margin (TTM)

ATNM32.2%

GRDX-12994.7%

FCF Margin (TTM)

ATNM-66.2%

GRDX-5062.9%

Net Income (TTM)

ATNM$11M

GRDX$-21M

FCF (TTM)

ATNM$-23M

GRDX$-8M

EPS (TTM)

ATNM$0.36

GRDX-$3.25

ROE (TTM)

ATNM83.4%

GRDX-5679.0%

ROA (TTM)

ATNM23.4%

GRDX-3050.0%

ROIC (TTM)

ATNM83.4%

GRDX-5425.0%

Cash

ATNM$36M

GRDX$1M

Debt

ATNM$5K

GRDX$2M

Net Cash/Debt

ATNM$36M

GRDX$-297K

Current Ratio (TTM)

ATNM4.08x

GRDX0.16x

Quick Ratio (TTM)

ATNM3.94x

GRDX0.13x

Debt/Equity (TTM)

ATNM0.00x

GRDX0.12x

Debt/Assets (TTM)

ATNM0.0%

GRDX0.0%

Interest Coverage (TTM)

ATNMN/A

GRDXN/A

Net Debt/EBITDA (TTM)

ATNM0.00x

GRDX0.00x

Beta

ATNM0.33

GRDX1.72

52W Performance

ATNM-28.6%

GRDX24.2%

YTD Performance

ATNM-19.7%

GRDX-3.3%

% from 52W High

ATNM-36.8%

GRDX-28.3%

% from 52W Low

ATNM49.6%

GRDX165.8%

Asset Turnover (TTM)

ATNM0.73x

GRDX0.00x

FCF Yield (TTM)

ATNM-67.4%

GRDX-24.2%

Earnings Yield (TTM)

ATNM32.8%

GRDX-62.0%

Dividend Yield (TTM)

ATNMN/A

GRDXN/A

Rule of 40

ATNM-66.2

GRDX-5,062.9

EV/GP/RG

ATNMN/A

GRDXN/A

Ticker research

View ATNM research View GRDX research

Metric	ATNM Actinium Pharmaceuticals Inc	GRDX GridAI Technologies Corp
Market & Valuation
Market Cap	$35M	$34M
Enterprise Value	$-2M	$34M
Price	$1.10	$4.97
P/E Ratio	3.06x	N/A
P/S Ratio	0.98x	209.46x
EV/Sales	-0.06x	211.31x
EV/EBITDA	-0.20x	0.00x
P/B Ratio	1.21x	1.94x
P/FCF Ratio	N/A	N/A
EV/FCF	0.08x	-4.17x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$35M	$160K
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	-0.2%	0.0%
Profitability
Gross Margin (TTM)	0.0%	-815.2%
Operating Margin (TTM)	62.3%	0.0%
EBITDA Margin (TTM)	27.9%	-6577.4%
Net Margin (TTM)	32.2%	-12994.7%
FCF Margin (TTM)	-66.2%	-5062.9%
Net Income (TTM)	$11M	$-21M
FCF (TTM)	$-23M	$-8M
EPS (TTM)	$0.36	-$3.25
ROE (TTM)	83.4%	-5679.0%
ROA (TTM)	23.4%	-3050.0%
ROIC (TTM)	83.4%	-5425.0%
Financial Health
Cash	$36M	$1M
Debt	$5K	$2M
Net Cash/Debt	$36M	$-297K
Current Ratio (TTM)	4.08x	0.16x
Quick Ratio (TTM)	3.94x	0.13x
Debt/Equity (TTM)	0.00x	0.12x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.33	1.72
52W Performance	-28.6%	24.2%
YTD Performance	-19.7%	-3.3%
% from 52W High	-36.8%	-28.3%
% from 52W Low	49.6%	165.8%
Efficiency & Yields
Asset Turnover (TTM)	0.73x	0.00x
FCF Yield (TTM)	-67.4%	-24.2%
Earnings Yield (TTM)	32.8%	-62.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-66.2	-5,062.9
EV/GP/RG	N/A	N/A
Ticker research	View ATNM research	View GRDX research

Valuation

P/E Ratio

ATNM

3.06x

P/S Ratio

ATNM

0.98x

GRDX

209.46x

EV/FCF

GRDX

-4.17x

ATNM

0.08x

Growth & revenue

Forward Revenue Growth

GRDX

0.0%

ATNM

-0.2%

Profitability & performance

Gross Margin

ATNM

0.0%

GRDX

-815.2%

ROE

ATNM

83.4%

GRDX

-5679.0%

FCF Yield %

GRDX

-24.2%

ATNM

-67.4%

52-Week Performance

GRDX

24.2%

ATNM

-28.6%

Detailed metrics comparison

ATNM

Actinium Pharmaceuticals Inc

GRDX

GridAI Technologies Corp

Market Cap

ATNM$35M

GRDX$34M

Enterprise Value

ATNM$-2M

GRDX$34M

Price

ATNM$1.10

GRDX$4.97

P/E Ratio

ATNM3.06x

GRDXN/A

P/S Ratio

ATNM0.98x

GRDX209.46x

EV/Sales

ATNM-0.06x

GRDX211.31x

EV/EBITDA

ATNM-0.20x

GRDX0.00x

P/B Ratio

ATNM1.21x

GRDX1.94x

P/FCF Ratio

ATNMN/A

GRDXN/A

EV/FCF

ATNM0.08x

GRDX-4.17x

PEG Ratio

ATNMN/A

GRDXN/A

Forward P/E (NTM)

ATNMN/A

GRDXN/A

Forward P/S (NTM)

ATNMN/A

GRDXN/A

Revenue (TTM)

ATNM$35M

GRDX$160K

Revenue Growth (YoY)

ATNMN/A

GRDXN/A

Forward Rev Growth

ATNM-0.2%

GRDX0.0%

Gross Margin (TTM)

ATNM0.0%

GRDX-815.2%

Operating Margin (TTM)

ATNM62.3%

GRDX0.0%

EBITDA Margin (TTM)

ATNM27.9%

GRDX-6577.4%

Net Margin (TTM)

ATNM32.2%

GRDX-12994.7%

FCF Margin (TTM)

ATNM-66.2%

GRDX-5062.9%

Net Income (TTM)

ATNM$11M

GRDX$-21M

FCF (TTM)

ATNM$-23M

GRDX$-8M

EPS (TTM)

ATNM$0.36

GRDX-$3.25

ROE (TTM)

ATNM83.4%

GRDX-5679.0%

ROA (TTM)

ATNM23.4%

GRDX-3050.0%

ROIC (TTM)

ATNM83.4%

GRDX-5425.0%

Cash

ATNM$36M

GRDX$1M

Debt

ATNM$5K

GRDX$2M

Net Cash/Debt

ATNM$36M

GRDX$-297K

Current Ratio (TTM)

ATNM4.08x

GRDX0.16x

Quick Ratio (TTM)

ATNM3.94x

GRDX0.13x

Debt/Equity (TTM)

ATNM0.00x

GRDX0.12x

Debt/Assets (TTM)

ATNM0.0%

GRDX0.0%

Interest Coverage (TTM)

ATNMN/A

GRDXN/A

Net Debt/EBITDA (TTM)

ATNM0.00x

GRDX0.00x

Beta

ATNM0.33

GRDX1.72

52W Performance

ATNM-28.6%

GRDX24.2%

YTD Performance

ATNM-19.7%

GRDX-3.3%

% from 52W High

ATNM-36.8%

GRDX-28.3%

% from 52W Low

ATNM49.6%

GRDX165.8%

Asset Turnover (TTM)

ATNM0.73x

GRDX0.00x

FCF Yield (TTM)

ATNM-67.4%

GRDX-24.2%

Earnings Yield (TTM)

ATNM32.8%

GRDX-62.0%

Dividend Yield (TTM)

ATNMN/A

GRDXN/A

Rule of 40

ATNM-66.2

GRDX-5,062.9

EV/GP/RG

ATNMN/A

GRDXN/A

Ticker research

View ATNM research View GRDX research

Metric	ATNM Actinium Pharmaceuticals Inc	GRDX GridAI Technologies Corp
Market & Valuation
Market Cap	$35M	$34M
Enterprise Value	$-2M	$34M
Price	$1.10	$4.97
P/E Ratio	3.06x	N/A
P/S Ratio	0.98x	209.46x
EV/Sales	-0.06x	211.31x
EV/EBITDA	-0.20x	0.00x
P/B Ratio	1.21x	1.94x
P/FCF Ratio	N/A	N/A
EV/FCF	0.08x	-4.17x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$35M	$160K
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	-0.2%	0.0%
Profitability
Gross Margin (TTM)	0.0%	-815.2%
Operating Margin (TTM)	62.3%	0.0%
EBITDA Margin (TTM)	27.9%	-6577.4%
Net Margin (TTM)	32.2%	-12994.7%
FCF Margin (TTM)	-66.2%	-5062.9%
Net Income (TTM)	$11M	$-21M
FCF (TTM)	$-23M	$-8M
EPS (TTM)	$0.36	-$3.25
ROE (TTM)	83.4%	-5679.0%
ROA (TTM)	23.4%	-3050.0%
ROIC (TTM)	83.4%	-5425.0%
Financial Health
Cash	$36M	$1M
Debt	$5K	$2M
Net Cash/Debt	$36M	$-297K
Current Ratio (TTM)	4.08x	0.16x
Quick Ratio (TTM)	3.94x	0.13x
Debt/Equity (TTM)	0.00x	0.12x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.33	1.72
52W Performance	-28.6%	24.2%
YTD Performance	-19.7%	-3.3%
% from 52W High	-36.8%	-28.3%
% from 52W Low	49.6%	165.8%
Efficiency & Yields
Asset Turnover (TTM)	0.73x	0.00x
FCF Yield (TTM)	-67.4%	-24.2%
Earnings Yield (TTM)	32.8%	-62.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-66.2	-5,062.9
EV/GP/RG	N/A	N/A
Ticker research	View ATNM research	View GRDX research